Cardiac Pacemakers and Defibrillators

32 Cardiac Pacemakers and Defibrillators



Technological advances have improved the versatility and function of implantable devices used to treat bradyarrhythmias and tachyarrhythmias. Surgical placement of pacemakers and implantable cardioverter defibrillators (ICDs) can be performed on an outpatient basis, with low risk and minimal morbidity, allowing the majority of patients to return to full functional capacity quickly.



Indications for Implantation of Cardiac Rhythm Devices




Biventricular Pacemakers


Based on the concept that “dyssynchronous” electrical activation of the left ventricle—as with bundle branch block or right ventricular pacing—translates to inefficiency of cardiac function, biventricular pacing has been developed as a therapeutic approach for patients with impaired cardiac function who would not otherwise have an indication for pacemaker therapy (Fig. 32-2). For instance, in patients with left bundle branch block, delayed electrical activation of the lateral wall of the left ventricle leads to delayed contraction of this same wall. In an individual with normal systolic function, delayed contraction of the lateral wall of the left ventricle may not result in any significant decrement in function. However, in an individual with markedly impaired left ventricular function, the disorganized ventricular contraction resulting from left bundle branch block can result in decreased pumping efficiency and increased mitral regurgitation. By positioning pacemaker leads in the right ventricle and in a lateral branch of the coronary sinus on the epicardium of the left ventricle, simultaneous pacing of both walls of the left ventricle improves ventricular synchrony. Biventricular pacing is indicated for treatment of patients with symptomatic heart failure (New York Heart Association class III or IV) despite optimal medical therapy, reduced left ventricular ejection fraction, and a widened QRS duration (either intrinsically or due to chronic need for pacing).




Implantable Cardioverter Defibrillators


ICDs are indicated for patients with structural heart disease at risk for malignant ventricular tachyarrhythmias (i.e., ventricular tachycardia or ventricular fibrillation). These indications include patients with a prior history of resuscitated cardiac arrest or ventricular tachycardia as well as patients at high risk for future cardiac arrest or ventricular tachyarrhythmia such as a patient with ischemic or nonischemic cardiomyopathy or hypertrophic cardiomyopathy. ICDs are also often indicated in patients with structurally normal hearts who are at high risk for ventricular tachyarrhythmias, such as those with inherited disorders of cardiac rhythm: long QT syndrome, Brugada syndrome, or catecholaminergic polymorphic ventricular tachycardia. The indications for ICD implantation, particularly in patients with tachyarrhythmias, are discussed in detail in this chapter and summarized in Figure 32-3.



Jun 12, 2016 | Posted by in CARDIOLOGY | Comments Off on Cardiac Pacemakers and Defibrillators

Full access? Get Clinical Tree

Get Clinical Tree app for offline access